INSIGHTS ON CLINICAL TRIAL TECHNOLOGIES
-
AI Meets Informed Consent: Opportunity, Risk, And What IRBs Need To See
Expert perspectives on IRB oversight, health literacy, and research ethics offer practical guidance to strengthen consent, protect participants, and align compliance with real-world research.
-
How To Make Your Clinical Trial Protocol More IRT/RTSM Friendly?
Simplifying and standardizing protocol elements strengthens RTSM builds by creating clear, repeatable structures that cut risk and boost reliability across the study lifecycle.
-
Electronic Clinical Outcome Assessments (eCOA) In Clinical Trials
Manual outcome tracking creates compliance gaps and data quality risks. Electronic assessments help trial teams capture cleaner data, faster.
-
Future Predictions For Clinical Technologies
In 2025, sponsors are prioritizing configurable, interoperable solutions that integrate seamlessly across IRT, eCOA, CTMS, eConsent, and supply chain systems.
-
Rethinking RTSM Software: When Bigger Isn't Better3/9/2026
Don’t let legacy vendor inertia jeopardize your trial. Discover why agility and deep RTSM expertise are the new benchmarks for reducing risk and ensuring precision in clinical operations.
-
When It Comes To IRT/RTSM In Your Clinical Trials, Speed Isn't Always A Good Thing3/25/2026
This clip shows why speed alone isn’t enough in clinical trials, stressing the need for thoughtful design, operational alignment, and long‑term reliability when pressure to move fast rises.
-
The Patient Experience Paradox: eCOA Strategy Overhaul3/25/2026
European regulatory shifts now require the systematic integration of patient data. Success depends on aligning clinical and market access strategies through rigorous evidence generation.
-
Policy To Practice: PBM Reform, TrumpRx, And Global Drug Development3/4/2026
Policy shifts are reshaping PBM oversight, driving transparent drug‑pricing tools, and influencing global responses that affect affordability, access, and future pharma development.
-
CRO Uses CRIO eSource To Double Monitoring Productivity1/31/2025
Examine the transformative impact of eSource technology on monitoring productivity during a global Phase 3 trial conducted by a Contract Research Organization (CRO) amid the COVID-19 pandemic.
CLINICAL TRIAL TECHNOLOGY SOLUTIONS
-
IQVIA eTMF Expert Services provide on-demand resources to help manage, monitor, and maintain eTMFs. Dive into the ways these services can improve productivity and ensure compliance.
-
Discover a flexible, cost-effective platform tailored to Phase I studies, providing rapid, efficient study builds, seamless transitions, and scalable solutions for early-stage clinical research.
-
Explore practical ways to simplify complex oncology studies with unified data, streamlined workflows, and more supportive patient and site experiences.
-
Generate accurate study budgets faster with the industry’s most contemporary fair market value (FMV) data for investigator grant costs based on real-world site costs.
-
The Australian Advantage is about saving time and minimizing costs while generating internationally accepted data in preparation for the next Phase.